Zynerba Pharma (ZYNE) Tops Q3 EPS by 3c

Zynerba Pharma (NASDAQ: ZYNE) reported Q3 EPS of ($0.20), $0.03 better than the analyst estimate of ($0.23).

For earnings history and earnings-related data on Zynerba Pharma (ZYNE) click here.

You May Also Be Interested In

• Is Treasury selloff a major issue for stock market bulls?
• BofA Securities Reiterates Buy Rating on Micron Technology (MU); Sees $230+ in EPS by FY30
• Vislink Technologies Inc. (VISL) Misses Q2 EPS by 7c